204 related articles for article (PubMed ID: 29730559)
1. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
[TBL] [Abstract][Full Text] [Related]
2. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
3. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
[TBL] [Abstract][Full Text] [Related]
4. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.
Wurbel MA; McIntire MG; Dwyer P; Fiebiger E
PLoS One; 2011 Jan; 6(1):e16442. PubMed ID: 21283540
[TBL] [Abstract][Full Text] [Related]
5. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.
Trivedi PJ; Bruns T; Ward S; Mai M; Schmidt C; Hirschfield GM; Weston CJ; Adams DH
J Autoimmun; 2016 Apr; 68():98-104. PubMed ID: 26873648
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa.
Hosoe N; Miura S; Watanabe C; Tsuzuki Y; Hokari R; Oyama T; Fujiyama Y; Nagata H; Ishii H
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G458-66. PubMed ID: 14592943
[TBL] [Abstract][Full Text] [Related]
7. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
Walters MJ; Wang Y; Lai N; Baumgart T; Zhao BN; Dairaghi DJ; Bekker P; Ertl LS; Penfold ME; Jaen JC; Keshav S; Wendt E; Pennell A; Ungashe S; Wei Z; Wright JJ; Schall TJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):61-9. PubMed ID: 20660125
[TBL] [Abstract][Full Text] [Related]
9. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
[TBL] [Abstract][Full Text] [Related]
10. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system.
Papadakis KA; Prehn J; Nelson V; Cheng L; Binder SW; Ponath PD; Andrew DP; Targan SR
J Immunol; 2000 Nov; 165(9):5069-76. PubMed ID: 11046037
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
[TBL] [Abstract][Full Text] [Related]
12. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
Hieshima K; Kawasaki Y; Hanamoto H; Nakayama T; Nagakubo D; Kanamaru A; Yoshie O
J Immunol; 2004 Sep; 173(6):3668-75. PubMed ID: 15356112
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids Suppress CCR9-Mediated Chemotaxis, Calcium Flux, and Adhesion to MAdCAM-1 in Human T Cells.
Wendt E; White GE; Ferry H; Huhn M; Greaves DR; Keshav S
J Immunol; 2016 May; 196(9):3910-9. PubMed ID: 27016601
[TBL] [Abstract][Full Text] [Related]
15. Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone Galphai2-deficient mice.
Elgbratt K; Bjursten M; Willén R; Bland PW; Hörnquist EH
Immunology; 2007 Oct; 122(2):199-209. PubMed ID: 17490434
[TBL] [Abstract][Full Text] [Related]
16. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
Wurbel MA; Malissen M; Guy-Grand D; Meffre E; Nussenzweig MC; Richelme M; Carrier A; Malissen B
Blood; 2001 Nov; 98(9):2626-32. PubMed ID: 11675330
[TBL] [Abstract][Full Text] [Related]
17. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
18. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria.
Wurbel MA; Malissen M; Guy-Grand D; Malissen B; Campbell JJ
J Immunol; 2007 Jun; 178(12):7598-606. PubMed ID: 17548595
[TBL] [Abstract][Full Text] [Related]
19. CCR9+ plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice.
Mizuno S; Kanai T; Mikami Y; Sujino T; Ono Y; Hayashi A; Handa T; Matsumoto A; Nakamoto N; Matsuoka K; Hisamatsu T; Takaishi H; Hibi T
Immunol Lett; 2012 Aug; 146(1-2):64-9. PubMed ID: 22626536
[TBL] [Abstract][Full Text] [Related]
20. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
